The therapeutic potential of laquinimod for Huntington's disease: A systematic review of preclinical and clinical studies
{{output}}
Introduction: Neuroinflammation is a central contributor to Huntington's disease (HD) pathogenesis and represents a promising therapeutic target. Laquinimod, an oral immunomodulator with demonstrated neuroprotective effects in p... ...
